SARS, MERS, COVID-19: Repurposing Drugs for a Pan-Coronavirus Treatment Medical Countermeasures October 15, 2020 …
MIS-C Detection: BARDA Invests in Rapid Diagnostic for Pediatric Complication of SARS-CoV-2 Biodetection October 15, 2020 …
U.S. Invests in Pandemic Vaccine Manufacturing Capacity with $31M Contract to Cytiva Industry News October 15, 2020 …
Dublin-Boston Scoring System Helps Predict Which COVID-19 Patients Will Develop Severe Infection Infectious Diseases October 14, 2020 …
W. Virginia CBRN Response Enterprise Assists with COVID-19 Testing Innovation Roll Out CBRNE October 13, 2020 …
UArizona Researchers Publish Latest on SARS-COV-2 Lasting Immunity Antibody Testing Project Biosurveillance October 13, 2020 …
Bacterial Toxin with Healing Effect: Staphylococcus aureus Substance Stimulates Tissue Regeneration Pathogens October 13, 2020 …
Stopping Lethal Lung Damage from Influenza: MG53 Protein Shows Promise in Animal Models Medical Countermeasures October 13, 2020 …
Scientists Engineer Bacteria-Killing Molecules from Wasp Venom Antimicrobial Resistance October 13, 2020 …
High Dose Favipiravir Countered SARS-CoV-2 in Hamsters, Hydroxychloroquine Ineffective Medical Countermeasures October 10, 2020 …
BARDA and JPEO-CBRND Back Cepheid’s Multiplex Test for Influenza, SARS-CoV2 and RSV Biodetection October 8, 2020 …
Scientists Publish First In-Depth Look at How CD4+ T Cells Fight SARS-CoV-2 Outbreak News October 8, 2020 …
New Study Shows Coronavirus Antibodies Last at Least Three Months After Infection Outbreak News October 8, 2020 …
Harvard Wyss Institute Licenses Diagnostic Technologies to Agile Biodetection Biodetection October 8, 2020 …
Pipeline COVID-19 Vaccines Not Affected by ‘G-Strain’ Mutation Medical Countermeasures October 8, 2020 …
